Karla MacDonald

Ms. Karla MacDonald

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Environmental Pollution
Verified
Journal Article
Open access
AMA. Martínez-Ibarra
A. Martínez-Ibarra
LML.D. Martínez-Razo
L.D. Martínez-Razo
KMKarla MacDonald
Karla MacDonald
MMMiguel Morales
Miguel Morales
EVE.R. Vázquez-Martínez
E.R. Vázquez-Martínez
MCMarco Cerbón
Marco Cerbón
A vast amount of evidence indicates that bisphenol A (BPA) and phthalates are widely distributed in the environment since these compounds are mass-produced for the manufacture of plastics and plasticizers. These compounds belong to a large group of substances termed endocrine-disrupting chemicals (EDC). It is well known that humans and living organisms are unavoidably and unintentionally exposed to BPA and phthalates from food packaging materials and many other everyday products. BPA and phthalates exert their effect by interfering with hormone synthesis, bioavailability, and action, thereby altering cellular proliferation and differentiation, tissue development, and the regulation of several physiological processes. In fact, these EDC can alter fetal programming at an epigenetic level, which can be transgenerational transmitted and may be involved in the development of various chronic pathologies later in the adulthood, including metabolic, reproductive and degenerative diseases, and certain types of cancer. In this review, we describe the most recent proposed mechanisms of action of these EDC and offer a compelling selection of experimental, epidemiological and clinical studies, which show evidence of how exposure to these pollutants affects our health during development, and their association with a wide range of reproductive, metabolic and neurological diseases, as well as hormone-related cancers. We stress the importance of concern in the general population and the urgent need for the medical health care system to closely monitor EDC levels in the population due to unavoidable and involuntary exposure to these pollutants and their impact on human health.

1 July 2021 in Annals of Hepatology
Verified
Journal Article
Open access
KMKarla MacDonald
Karla MacDonald
LMLayla Michán
Layla Michán
AMAlejandra Martínez-Ibarra
Alejandra Martínez-Ibarra
MCMarco Cerbón
Marco Cerbón
Silymarin is obtained from the Milk thistle plant Silybum marianum and has been used over the centuries to treat principally liver disease, although it has also been studied for its beneficial effects in cardioprotection, neuroprotection, immune modulation, and cancer among others. Importantly, silymarin's active component silybin is a flavonolignan that exhibits different activities such as; scavenger, anti-oxidant, anti-inflammatory, and recently revealed, insulin-sensitizing properties which have been explored in clinical trials in patients with insulin resistance. In this review, we summarize the most relevant research of silymarin's effect on lipid and carbohydrate metabolism, focusing the attention on insulin resistance, which is well known to play a crucial role in metabolic disease progression.

27 May 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
KMKarla MacDonald
Karla MacDonald
AMAlejandra Martínez-Ibarra
Alejandra Martínez-Ibarra
AMAdriana Monroy
Adriana Monroy
JMJuan Miranda-Ríos
Juan Miranda-Ríos
MCMarco Cerbón
Marco Cerbón
Dietary fatty acids (DFAs) play key roles in different metabolic processes in humans and other mammals. DFAs have been considered beneficial for health, particularly polyunsaturated (PUFAs) and monounsaturated fatty acids (MUFAs). Additionally, microRNAs (miRNAs) exert their function on DFA metabolism by modulating gene expression, and have drawn great attention for their potential as biomarkers and therapeutic targets. This review explicitly examined the effects of DFAs on miRNA expression associated with metabolic diseases, such as obesity, non-alcoholic fatty liver disease (NAFLD), and cardiovascular disease (CVD), as well as inflammation, published in the last ten years. DFAs have been shown to induce and repress miRNA expression associated with metabolic disease and inflammation in different cell types and organisms, both in vivo and in vitro, depending on varying combinations of DFAs, doses, and the duration of treatment. However, studies are limited and heterogeneous in methodology. Additionally, recent studies demonstrated that high fat ketogenic diets, many enriched with saturated fats, do not increase serum saturated fat content in humans, and are not associated with increased inflammation. Thus, these findings shed light on the complexity of novel treatment and DFA interventions for metabolic disease and to maintain health. Further studies are needed to advance molecular therapeutic approaches, including miRNA-based strategies in human health and disease.

1 January 2019 in Immunobiology
Verified
Journal Article
Open access
KMKarla MacDonald
Karla MacDonald
MAMarcia Arenas-Hernandez
Marcia Arenas-Hernandez
IMIsmael Mancilla-Herrera
Ismael Mancilla-Herrera
Claudia Rangel-EscareñoClaudia Rangel-Escareño
Claudia Rangel-Escareño
RVRodrigo Vega-Sánchez
Rodrigo Vega-Sánchez
Leukocytes found at the human maternal-fetal interface participate in the inflammatory process associated with both preterm and term labor; therein, effective methods for their isolation that allow further phenotypic and functional analyses are necessary. Leukocyte isolation is usually carried out through scraping or enzyme digestion of the choriodecidua, however both methods usually limit the use of downstream immunophenotyping or transcriptomic techniques. Here we describe an isolation method based on gentle trypsin digestion that yields a leukocyte-enriched cell mixture with high lymphocyte viability, although less viable myeloid cells. We show that the method does not compromise cell surface markers since isolated leukocytes are suitable for flow cytometry; and that high quality RNA can be obtained from these cells for qRT-PCR and microarray analyses.

11 December 2020 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
KMKarla MacDonald
Karla MacDonald
RVRodrigo Vega-Sánchez
Rodrigo Vega-Sánchez
Background: Human labor is associated with an inflammatory process that takes place at the maternal–fetal interface, where leukocytes infiltrate and contribute to the local production of effector molecules such as cytokines, chemokines, MMPs, etc. This process may be altered by a low‐grade chronic inflammation, characteristic of obesity, resulting in adverse pregnancy outcomes. In this cross‐sectional pilot study, we analyzed the relationship between maternal adiposity and inflammation‐related gene expression in leukocytes from six healthy women with term pregnancies without labor.Methods: We estimated maternal adiposity and examined the relative expression of 211 inflammation‐related genes in maternal peripheral blood leukocytes (MAT), placental intervillous blood leukocytes (PLA), and choriodecidual leukocytes (CHD) by real‐time qPCR. Finally, we analyzed the correlation between maternal adiposity and gene expression.Results: Participants’ adiposity ranged from 27.6% to 61.1% (n = 6). The expression of 23 genes significantly differed (p < 0.05) in MAT, PLA, and CHD leukocytes, most of which code for chemokines and proinflammatory cytokines. Importantly, increasing maternal adiposity correlated (r > 0.7) mostly positively with the expression of genes related to activation, migration, infiltration, and proinflammation in MAT (36 genes) and PLA (31 genes). In contrast, in CHD leukocytes maternal adiposity correlated only negatively with seven genes, involved in migration and infiltration.Conclusion: Our findings suggest that during term pregnancy, increased maternal adiposity may enhance the priming of peripheral leukocytes, while in choriodecidua it may alter leukocyte recruitment and proinflammatory activity. Maternal adiposity must be considered an important variable in further studies that analyze inflammation‐related gene expression in pregnant women.